CENTESSA PHARMACEUTICALS (OREXIA) LIMITED

3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM  WA14 2DT
  • Active
  • Private Limited Company
  • Company No. 11607013
  • Last Updated: 01 Mar 2024

Company Profile

CENTESSA PHARMACEUTICALS (OREXIA) LIMITED was incorporated on Friday, October 5, 2018 as a Private Limited Company with registered address in ALTRINCHAM. CENTESSA PHARMACEUTICALS (OREXIA) LIMITED has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 6 years 4 months and 19 days.

Name CENTESSA PHARMACEUTICALS (OREXIA) LIMITED
Company number 11607013
Company type Private Limited Company
Incorporation date 05 Oct 2018
Status Active
Industry (SIC 2007)

Address

Registered Address 3RD FLOOR
1 ASHLEY ROAD
ALTRINCHAM
WA14 2DT
Country Of Origin UNITED KINGDOM

Map based on PostCode

Ownership Information

Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.

Name Nature of Control
Centessa Pharmaceuticals (Uk) Limited 1 Ashley Road, WA14 2DT Dates: Tuesday, December 20, 2022 - present
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors
Centessa Pharmaceuticals Plc 1 Ashley Road, WA14 2DT Dates: Friday, January 29, 2021 - Tuesday, December 20, 2022
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors

Accounts and Confirmation

Type of accounts SMALL
End of financial Year 31 December
Next annual accounts due 30 September 2024, (-147 days left)
Latest accounts 31 December 2022
Next confirmation statement due 02 November 2019
Last confirmation statement dated Not available

Mortgages

Total of Mortgages 3
Mortgages Outstanding 3
Mortgages Partially Satisfied 0
Mortgages Satisfied/Paid 0

Previous Names

Name Change Date
CENTESSA PHARMACEUTICALS (OREXIA) LIMITED 05 Oct 2018
OREXIA LIMITED 24 Feb 2021
OREXIA THERAPEUTICS LIMITED 03 Apr 2023